APA (7th ed.) Citation

Sonpavde, G., Catalano, P. J., Michor, F., Graser, C. J., & McDonald, T. O. Early dynamics of clinical and laboratory parameters predict primary refractory disease in patients with metastatic urothelial carcinoma receiving atezolizumab. BMJ Publishing Group.

Chicago Style (17th ed.) Citation

Sonpavde, Guru, Paul J. Catalano, Franziska Michor, Christopher J. Graser, and Thomas O. McDonald. Early Dynamics of Clinical and Laboratory Parameters Predict Primary Refractory Disease in Patients with Metastatic Urothelial Carcinoma Receiving Atezolizumab. BMJ Publishing Group.

MLA (9th ed.) Citation

Sonpavde, Guru, et al. Early Dynamics of Clinical and Laboratory Parameters Predict Primary Refractory Disease in Patients with Metastatic Urothelial Carcinoma Receiving Atezolizumab. BMJ Publishing Group.